The Effect of Mounjaro on Pregnancy — and What to Do Before, During and After

Step 1: Understand why pregnancy and tirzepatide do not mix right now

The absence of reassuring data is itself the clinical concern. Regulatory agencies and manufacturers do not say "this medicine harms pregnancy", they say the evidence to say it is safe simply does not exist. Animal reproductive studies raised signals at exposures in the range used clinically. That is enough for UK guidance to draw a firm line. The evidence base for tirzepatide's effects on pregnancy is reviewed in more detail elsewhere, but the practical upshot is straightforward: tirzepatide and pregnancy are not compatible under current licensing.

The NHS medicines page for tirzepatide states that women should stop taking it as soon as they know they are pregnant and seek medical advice. This is not a "discuss with your doctor first" situation, stop, then discuss. Your GP or specialist can advise on monitoring for the remainder of the pregnancy.

Women sometimes reach this page having just found out they are pregnant while on treatment. That discovery brings its own anxiety. The reassurance available is genuine: there is no established pattern of harm in humans at this point, and stopping promptly is the right and recognised response. If you want a fuller picture of what Mounjaro and pregnancy mean in practice, including the questions most women ask at this stage, that resource covers the topic in depth. Most GPs will refer you to a midwife or obstetrician who can monitor the pregnancy with the full picture in mind.

Step 2: Contraception during treatment, what changes, and when

Because tirzepatide slows gastric emptying, the absorption of oral contraceptive pills can be reduced, particularly in the first few weeks of starting or following a dose increase. NHS England's guidance on weight-management injections advises adding a non-oral method of contraception (barrier methods are the practical choice) for the first four weeks of treatment and for four weeks after each upward dose change. Semaglutide does not carry the same evidence-based concern, but for tirzepatide this is a specific, actionable precaution.

This is one of the things our prescribers discuss during every Mounjaro consultation. If you are on a combined pill or progestogen-only pill, the practical window where your usual contraception may be less reliable is time-limited and manageable, it just needs to be planned for. Women with PCOS considering Mounjaro and future pregnancy may find this contraception overlap especially worth understanding, since weight loss can restore ovulation even before a period returns.

For women using transdermal contraception (patches, implants, hormonal coils), the absorption question does not apply in the same way, your prescriber can confirm what is appropriate for your specific method.

Step 3: Planning to conceive, the wash-out question

If you are planning a pregnancy in the future, the question of when to stop Mounjaro is worth raising with your prescriber well in advance rather than at the last moment. There is no universally fixed wash-out period published in UK guidance for tirzepatide equivalent to, say, some teratogenic medicines, but the practical advice is to allow enough time that the medicine is cleared from your system before conception, and to ensure your weight and metabolic health are in a stable place before you stop.

Weight management before conception matters: higher BMI is associated with increased risks during pregnancy including gestational diabetes and pre-eclampsia, as the NHS obesity overview sets out. Mounjaro may help reach a healthier baseline before conception is attempted, but the decision about timing requires a clinical conversation, not a general rule. It is also worth knowing that tirzepatide can influence resting heart rate, a factor your prescriber may want to review as part of any pre-conception assessment. Whether Mounjaro affects a future pregnancy differently from a current one is a related question that often comes up alongside this one.

Once you have stopped and are ready to try to conceive, your GP is the right starting point, they can coordinate any monitoring needed and refer you to specialist maternity or obstetric care if your situation warrants it. Good weight, good nutrition, and a stable metabolic baseline give the best conditions for a healthy pregnancy.

Step 4: After pregnancy, returning to treatment

Breastfeeding is a second period during which tirzepatide is not recommended. It is not known whether tirzepatide passes into breast milk in clinically significant amounts, and until that data exists the precautionary position applies. Again, this is a conversation for your midwife, GP or specialist, not something to navigate alone.

For many women, returning to weight management after pregnancy and breastfeeding is a priority. At that point, a fresh clinical assessment determines whether tirzepatide is appropriate to restart. Checking your eligibility through a free consultation at that stage is straightforward; our prescribers carry out same-day clinical reviews and your past treatment history is taken into account. The pen that eventually arrives (tracked by DPD in plain, unbranded packaging) is exactly the same licensed Mounjaro supplied through the UK authorised supply chain as before.

If you have questions about the service or want to talk through your situation before committing to a consultation, our support team is reachable seven days a week. And if you want to understand more about tirzepatide as a treatment generally, our weight-loss treatment overview covers the broader landscape.